Severe/Moderate Coronavirus

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Severe/Moderate Coronavirus trials you may qualify for

100

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingPhase 1/2

NCT04565665

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

This is a phase I trial followed by a phase II randomized trial. The purpose of phase I study is the feasibility of treating patients with acute respiratory dis…

United States70 participantsStarted 2020-07-29

Treatment: Best Practice, Mesenchymal Stem Cell

RecruitingNot Applicable

NCT06490744

Evolution of Respiratory Function in Lung Transplant Patients With Moderate to Severe Covid-19 Infection

The SARS-Cov-2 infection pandemic has caused a large number of acute respiratory failures and deaths across the world. Certain factors have been identified as a…

France75 participantsStarted 2023-09-04

All recent trials (100 shown)

TerminatedPhase 3

NCT04516811

Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19

A prospective, randomized, placebo-controlled, double-blinded, phase III clinical trial of the therapeutic use of convalescent plasma in the treatment of patien…

South Africa102 participantsStarted 2020-09-21

Treatment: COVID-19 convalescent plasma (CCP) plus standard of care (SOC), Standard of care (SOC) plus placebo

CompletedPhase 2/3

NCT04494984

A Study to Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19.

This study aims to analyze the efficacy and safety of passive immunotherapy by administering an equine hyperimmune serum (INM005) against the SARS-CoV-2 recepto…

Argentina243 participantsStarted 2020-07-27

Treatment: INM005, Placebo

Severe/Moderate Coronavirus

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

Evolution of Respiratory Function in Lung Transplant Patients With Moderate to Severe Covid-19 Infection

All recent trials (100 shown)

Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19

A Study to Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19.

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

Evolution of Respiratory Function in Lung Transplant Patients With Moderate to Severe Covid-19 Infection

All recent trials (100 shown)

Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19

A Study to Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19.

Calprotectin, a Biomarker of COVID-19 Severity (CALPRO)

A US Study to Look at Loss of Work and Healthcare Costs for People Affected With Mild-to-moderate COVID 19 Who Have High…

Study of LAU-7b for the Treatment of Long COVID in Adults

Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS

Ultraprotective Ventilation Without Extracorporeal Circulation During COVID 19 Pneumonia

A Study to Learn About the Study Medicine (Nirmatrelvir Plus Ritonavir) in Pregnant Women With COVID-19

A Trial of Aclaris Therapeutics, Inc. (ATI)-450 in Patients With Moderate-severe Novel Coronavirus Disease 2019 (COVID-1…

Study of Niclosamide in Moderate and Severe Hospitalized Coronavirus-19 (COVID-19) Patients

Treat COVID-19 Patients With Regadenoson

Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)

Transcranial Non-invasive Electrical Stimulation of the Vagus Nerve in Hospitalized Moderate-to-severe COVID-19 Patients

Tafenoquine in Patients With Mild to Moderate COVID-19

Enoxaparin in COVID-19 Moderate to Severe Hospitalized Patients

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-…

An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving t…

Trial to Evaluate Nitazoxanide for Treatment of Mild or Moderate COVID-19 in Subjects at High Risk of Severe Illness

A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease

Safety and Effectiveness of Placental Derived Exosomes and Umbilical Cord Mesenchymal Stem Cells in Moderate to Severe A…